Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo

Cholangiocarcinoma is the most common biliary duct malignancy and the second most common primary liver cancer, accounting for 10-20% of hepatic malignancies. With high mortality and poor prognosis, the 5-year survival rate of cholangiocarcinoma is only 10%. A previous study demonstrated a significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Tingting, Gong, Jian, Fujita, Koji, Nishiyama, Noriko, Iwama, Hisakazu, Liu, Shi, Nakahara, Mai, Yoneyama, Hirohito, Morishita, Asahiro, Nonura, Takako, Kobara, Hideki, Okano, Keiichi, Suzuki, Yasuyuki, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864011/
https://www.ncbi.nlm.nih.gov/pubmed/33491760
http://dx.doi.org/10.3892/ijo.2020.5165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864011/
https://www.ncbi.nlm.nih.gov/pubmed/33491760
http://dx.doi.org/10.3892/ijo.2020.5165

Ejemplares similares